The Short Version
Converging genetic, epidemiologic, and mechanistic evidence from multiple high-authority sources firmly establishes lipoprotein(a) as a causal risk factor for atherosclerotic cardiovascular disease. Mendelian randomization studies, genome-wide association data, and biological plausibility all point in the same direction, and major medical bodies (CDC, ACC, European Atherosclerosis Society) endorse this causal interpretation. Minor caveats exist—mechanistic pathways are not fully mapped, and effect sizes vary somewhat by ancestry—but these do not undermine the core causal conclusion.